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ommendations were developed with limited data
and further research is needed to find cost-effective
ways to control the spread of vancomycin resistance,
HICPAC strongly encourages hospitals to develop
their own institution-specific plans, which should
stress the following elements: 1) prudent vancomy-
cin use by clinicians, 2) education of hospital staff
regarding vancomycin resistance, 3) early detection
and prompt reporting of vancomycin resistance in
enterococci and other gram-positive  microorgan-
isms by the hospital microbiology laboratory, and 4)
immediate implementation of appropriate infection-
control measures to prevent person-to-person trans-
mission of VRE.
The recommendations were developed by
HICPAC’s Subcommittee on the Prevention and
Control of Antimicrobial-Resistant Microorganisms
in Hospitals and subject-matter experts and repre-
sentatives of the American Hospital Association,
American Society for Microbiology, Association for
Professionals in Infection Control and Epidemiol-
ogy, Infectious Diseases Society of America, Society
for Healthcare Epidemiology of America, and Surgi-
cal Infection Society. The recommendations were
published in February in Infection Control and Hos-
pital Epidemiology 1995;16:105-13 and will also be
published in the April 1995 issue of the American
Journal for Infection Control.
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Waterborne Cryptosporidiosis
Threat Addressed
Cryptosporidium parvum was first recognized as
a cause of human illness in 1976. From 1976 to 1982,
the disease was reported rarely in the United States,
primarily among the immunocompromised. In 1982,
the number of reported cases began to increase
dramatically along with the number of HIV-infected
persons; outbreaks among immunocompetent popu-
lations also were reported. Recent municipal water-
borne outbreaks of cryptosporidiosis in Texas (1984),
Georgia (1987), and Oregon (1992), and a massive
outbreak in Wisconsin in 1993 that affected more
than 400,000 persons have raised awareness about
the waterborne transmission of cryptosporidiosis.
Since 1993, several smaller cryptosporidiosis out-
breaks were reported in the United States: two were
related to drinking water, six were linked to recrea-
tional water, and one was foodborne.
Cryptosporidiosis is caused by ingestion of the
environmentally tough oocysts of the protozoan
parasite  C. parvum, an intracellular organism that
can replicate in the gut epithelial cells of most mam-
mals. Its oocyst is extremely resistant to chlorine,
which is commonly used to treat municipal water.
In healthy persons, the disease lasts 1 to 2 weeks
and can have considerable economic impact through
absenteeism of those affected. In the immunocom-
promised, the disease is often severe, lifelong, and
life-threatening. No effective therapy is available.
The magnitude of the 1993 Wisconsin outbreak
and its association with a municipal water plant
operating within existing state and federal regula-
tions underlined the need for improved surveillance
and coordination among public health agencies and
spurred efforts for regulatory standards for Crypto-
sporidium in drinking water. During 1995-1996, the
U.S. Environmental Protection Agency (EPA) in-
tends to implement the Information Collection Rule,
which requires utilities that serve populations of
100,000 or more and use surface water (lakes, rivers,
streams) to test that water routinely for Crypto-
sporidium oocysts. If oocysts are found, the utility
may also have to test finished water (tap water).
Utilities that serve populations of 10,000 to 99,000
will also have to test source water, but for a shorter
period. They will not be required to test tap water,
even if oocysts are found. Authority to issue boil
water advisories if oocysts are found varies from
state to state. The health risks from ingesting low
levels of Cryptosporidium are unknown. More than
300 representatives from 40 states and more than
25 regulatory, public health, water utility, and advo-
cacy groups met at the Centers for Disease Control
and Prevention (CDC) in Atlanta in September 1994
to discuss the prevention and control of waterborne
cryptosporidiosis. Recommendations from the CDC
workshop will be published in the next 2 to 3 months.
CDC held the first meeting of the Working Group
on Waterborne Cryptosporidiosis in November 1994.
The working group convenes biweekly by teleconfer-
ence. For more information about the group, contact
Margaret Hurd (phone: 404-488-7769, fax: 404-488-
7761).
The working group has three main purposes:
1) promote a regular exchange of ideas, goals, activi-
ties, and proposals among individual scientists,
agencies, and organizations interested in water-
borne cryptosporidiosis; 2) make decisions on public
health issues related to waterborne crypto-
sporidiosis; and 3) assemble smaller, more focused,
task forces with expertise to develop, implement,
and evaluate projects of the working group.
The working group has created task forces to
assist local, state, and national public health depart-
ments, water utilities, and regulatory agencies in
preparing for and managing outbreaks. The task
forces have the following responsibilities:
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about cryptosporidiosis.
· Develop guidelines on when to initiate or end boil
water advisories.
· Help formulate the language for EPA’s Informa-
tion Collection Rule.
· Identify officials with authority to issue boil
water advisories. Examine legal issues associ-
ated with boil water advisories and the environ-
mental testing, surveillance, and diagnostic
requirements for waterborne Cryptosporidium.
In addition, technical task forces will collect data
to develop guidelines for persons who may want to
use bottled water and personal-use water filters and
provide updates on the status of environmental sam-
pling, water testing, and surrogate indicators of Cryp-
tosporidium oocysts. These task forces will also
report on the status of clinical diagnostic and
serologic tools and provide local cryptosporidiosis
infection rates to use in assessing the risk for water-
borne transmission.
C. parvum oocysts are present in most surface
water supplies; better technological tools and
epidemiologic assessments are needed to determine
the public health risks from these oocysts. Until the
risks are fully known, efforts should be made to
inform the public about cryptosporidiosis. Informa-
tion on opportunistic infections, including crypto-
sporidiosis, for physicians who treat diseases in
immunocompromised patients will be published
this fall in a supplement to Clinical Infectious Dis-
eases by authors from CDC and the Infectious Dis-
eases Society of America.
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